Eisai and Purdue Pharma present efficacy and safety data from second pivotal phase 3 insomnia study

This article was originally published here

Data were presented at the Sleep Research Society’s Advances in Sleep and Circadian Science conference, taking place in Clearwater Beach, Florida, Feb. 1-4, 2019. SUNRISE 2 was a

The post Eisai and Purdue Pharma present efficacy and safety data from second pivotal phase 3 insomnia study appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply